EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,852,000 | +7.8% | 31,837 | +24.3% | 0.44% | -4.0% |
| Q3 2020 | $2,645,000 | -59.2% | 25,606 | -68.7% | 0.45% | -60.5% |
| Q2 2020 | $6,478,000 | +20.7% | 81,919 | -11.7% | 1.15% | +6.6% |
| Q1 2020 | $5,367,000 | -1.3% | 92,759 | -8.0% | 1.08% | +65.0% |
| Q4 2019 | $5,439,000 | -30.3% | 100,831 | -32.4% | 0.65% | -21.4% |
| Q3 2019 | $7,800,000 | +8.0% | 149,211 | -0.2% | 0.83% | +7.6% |
| Q2 2019 | $7,222,000 | -13.6% | 149,495 | -9.6% | 0.77% | -8.0% |
| Q1 2019 | $8,354,000 | -30.4% | 165,353 | -18.4% | 0.84% | -37.3% |
| Q4 2018 | $12,010,000 | -11.9% | 202,595 | -2.1% | 1.34% | +12.1% |
| Q3 2018 | $13,629,000 | +28.0% | 207,027 | -1.8% | 1.20% | +30.5% |
| Q2 2018 | $10,647,000 | +32.1% | 210,866 | +37.7% | 0.92% | +26.2% |
| Q1 2018 | $8,061,000 | – | 153,106 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |